Growth Metrics

Insulet (PODD) EBT Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.50%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.26%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -8.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 5.78%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 103.34%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 74.66%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.02%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 54.33%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 134.44%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 134.44%
Dec 31, 2025 25.85%
Sep 30, 2025 48.13%
Jun 30, 2025 -44.42%
Mar 31, 2025 -12.20%
Dec 31, 2024 3.24%
Sep 30, 2024 54.38%
Jun 30, 2024 79.30%
Mar 31, 2024 123.17%
Dec 31, 2023 383.86%
Sep 30, 2023 1,042.11%
Jun 30, 2023 178.95%
Mar 31, 2023 -16.04%
Dec 31, 2022 -33.23%
Sep 30, 2022 -137.50%
Jun 30, 2022 -27.11%
Mar 31, 2022 9,666.67%
Dec 31, 2021 280.54%
Sep 30, 2021 13.43%
Jun 30, 2021 -263.22%
Mar 31, 2021 111.54%
Dec 31, 2020 -372.06%
Sep 30, 2020 1,118.18%
Jun 30, 2020 815.79%
Mar 31, 2020 -155.32%
Dec 31, 2019 -37.40%
Sep 30, 2019 -40.64%
Jun 30, 2019 248.55%
Mar 31, 2019 175.37%
Dec 31, 2018 256.36%
Sep 30, 2018 187.99%
Jun 30, 2018 83.32%
Mar 31, 2018 36.89%
Dec 31, 2017 22.43%
Sep 30, 2017 28.63%
Jun 30, 2017 -78.86%
Mar 31, 2017 7.00%
Dec 31, 2016 43.24%
Sep 30, 2016 83.55%
Jun 30, 2016 75.16%
Mar 31, 2016 -1.99%
Dec 31, 2015 -722.68%
Sep 30, 2015 -65.75%
Jun 30, 2015 40.63%
Mar 31, 2015 -71.38%
Dec 31, 2014 27.73%
Sep 30, 2014 49.15%
Jun 30, 2014 -179.39%
Mar 31, 2014 42.29%
Dec 31, 2013 73.79%
Sep 30, 2013 -71.81%
Jun 30, 2013 27.81%
Mar 31, 2013 28.51%
Dec 31, 2012 28.76%
Sep 30, 2012 8.65%
Jun 30, 2012 25.83%
Mar 31, 2012 -49.61%
Dec 31, 2011 31.86%
Sep 30, 2011 -12.08%
Jun 30, 2011 -41.66%